nMarq AF Catheter Ablation Trial
The nMarq trial, conducted in cooperation with Biosense Webster, involves the use of a new circular irrigation electrode catheter to perform curative ablation in patients with atrial fibrillation. The catheter is placed at the opening of the pulmonary veins in the hope that ablation from multiple poles simultaneously will shorten procedure times, enhance patient outcomes, and reduce patient risk. Our physicians are among few select individuals in the country who are involved in this exciting, promising research trial
Join HRS in Promoting AFib Awareness
Visit MyAFib.org to access our electronic "kit" of resources, including information sheets and brochure for patients; Managing the Patient with AFib and Rate and Rhythm Pocket Guides for providers; the CHADS2 Scorecard, and more! All materials are available for download or for purchase.


Ongoing clinical research projects include:
an evaluation of the medication ranolazine in the prevention of defibrillator shocks
involves the implantation of a novel sensor implanted by catheters into the heart's left atrium to improve the treatment of patients with advanced congestive heart failure
Doctor is looking at images on computer